Rationale Previously, we reported methods to estimate peak breath alcohol concentrations (BrAC) from transdermal alcohol concentrations (TAC) under conditions where alcohol consumption was controlled to produce similar BrAC levels in both sexes. Objective This study characterized differences in the relationship between BrAC and TAC as a function of sex and developed a model to predict peak BrAC that accounts for known sex differences in peak BrAC. Methods TAC and BrAC were monitored during the consumption of a varying number of beers on different days. Both men (n=11) and women (n=10) consumed one, two, three, four, and five beers at the same rate in a 2-h period. Sex and sex-related variables were considered for inclusion in a multilevel model to develop an equation to estimate peak BrAC levels from TAC. Results While peak BrAC levels were significantly higher in women than men, sex differences were not significant in observed TAC levels. This lack of correspondence was evidenced by significant sex differences in the relationship between peak TAC and peak BrAC. The best model to estimate peak BrAC accounted for sex-related differences by including peak TAC, time-to-peak TAC, and sex. This model was further validated using previously collected data. Conclusions The relationship between peak TAC and actual peak BrAC differs between men and women, and these differences can be accounted for in a statistical model to better estimate peak BrAC. Further studies are required to extend these estimates of peak BrAC to the outpatient environment where naturalistic drinking occurs.
Introduction
Excessive alcohol consumption is responsible for more than 79,000 deaths annually (CDC 2011) and is the third leading preventable cause of death in the USA (Mokdad et al. 2004) . Unhealthy levels of alcohol consumption increase the risk for health problems (Rehm et al. 2003a, b) and are associated with significant behavioral and economic consequences (Bouchery et al. 2011; CDC 2011) . NIAAA defines "unhealthy" levels as ≥4 drinks for women and ≥5 drinks for men during a single day. "Binge" drinking has been identified as particularly problematic and is defined as heavy drinking (four standard drinks for women and five for men) within a 2-h period, resulting in intoxicating levels, putting individuals at serious risk of medical, legal, and psychosocial problems (CDC 2012; NIAAA 2004 NIAAA , 2014 Wechsler and Nelson 2001) . A recent analysis (Bouchery et al. 2011 ) estimated that the cost of alcohol abuse was $223.5 billion in 2006. Consequently, sensitive and specific measures of alcohol consumption are needed to better understand the etiology of unhealthy levels of alcohol consumption to develop effective treatment and intervention strategies for reducing this dangerous behavior.
An accurate picture of drinking patterns among heavy drinkers is needed to make treatments and interventions for excessive drinking more effective. Despite adequate reliability and validity in research settings (Del Boca and Darkes 2003) , self-reported alcohol consumption still tends to be underestimated in real-world settings (de Visser and Birch 2012; Devos-Comby and Lange 2008; Kerr and Stockwell 2012; White et al. 2003) . The accuracy of self-reported drinking may be especially compromised when large quantities (i.e., binge) of alcohol are consumed (Sobell and Sobell 2003) . Furthermore, alcohol concentrations vary across beverage types, leading people to underestimate how much actual alcohol they have consumed (Devos-Comby and Lange 2008; White et al. 2003) .
Because of these inaccuracies, objective measures of alcohol consumption are required. Although several alcohol biomarkers have been developed, they either (1) have short halflives [e.g., breath and blood alcohol concentrations (hours), urinary ethyl glucuronide, urinary ethyl sulfate (days)] which limit their window of detection; (2) are non-specific (e.g., carbohydrate-deficient transferrin and γ-glutamyl transferase), possibly resulting in false positive results; or (3) need to be better characterized [e.g., phosphatidylethanol (Hahn et al. 2011; Helander et al. 2012; Javors and Johnson 2003; Marques et al. 2010; Marques 2012) ]. Transdermal alcohol monitoring is the direct electrochemical detection of the small amount (approximately1 %) of ingested alcohol that is excreted through the skin (Swift 2003) . The transdermal alcohol concentration (TAC) is the concentration of alcohol measured in the skin surface water vapor or insensible perspiration (Swift 2003; Swift et al. 1992) . Transdermal alcohol monitoring is a noninvasive method that continuously gathers data about an individual's drinking behavior in real time (Ayala et al. 2009; Barnett et al. 2011; Dougherty et al. 2012; Leffingwell et al. 2013; Marques and McKnight 2009; Sakai et al. 2006; Swift 2000 Swift , 2003 . Because TAC recordings reflect alcohol expired through the skin from the blood supply, we (Dougherty et al. 2012 ) and others (Marques and McKnight 2007; Sakai et al. 2006; Swift et al. 1992 ) observed high correlations between breath alcohol concentrations (BrAC) and TAC readings. Although TAC is highly correlated with breath and blood alcohol measurements, TAC readings lag behind BrAC by up to several hours because of the delays related to alcohol diffusion through the skin (Marques and McKnight 2007; Sakai et al 2006; Swift 2003) .
In a previous study (Dougherty et al. 2012) , we reported a formula to estimate peak BrAC from TAC readings because peak intoxication levels (the most clinically relevant outcome that relates closely to both health and safety standards) are typically described in terms of peak blood or breath alcohol concentration. We used the Secure Continuous Remote Alcohol Monitor (SCRAM-II TM ) to detect TAC after men and women drank varying amounts of alcohol in a laboratory setting. Because peak BrAC levels normally are higher in women than men when they drink similar amounts of alcohol at a similar rate of consumption (e.g., Baraona et al. 2001; Breslin et al. 1997; Dettling et al. 2007; Jones and Jones 1976) , the rate and amount of alcohol consumption was controlled in the previous study to achieve similar peak BrAC levels in both sexes. Women drank up to four beers at the rate of one every 30 min, and men drank up to five beers at the rate of one every 24 min. Unfortunately, by controlling the amount and rate of alcohol consumption to achieve comparable BrAC levels, we precluded any analysis of possible sex differences in TAC recordings that might occur consequent to normally expected sex differences in BrAC. There is one previous report suggesting that the relationship between TAC and BrAC may differ in women compared to men (Marques and McKnight 2009 )-specifically, they reported that the TAC-to-BrAC ratio was lower in women.
Therefore, the current study was conducted to characterize sex differences in the TAC and BrAC readings and the TACto-BrAC relationship so that a statistical model can predict peak BrAC levels from TAC readings and properly account for these sex differences. Differently from our previous study, the experimental design required men and women to consume the same amount of beer at the same rate so that sex-related differences in BrAC and TAC readings could be determined. This allowed for the development of a statistical model to account for sex-related differences in the relationship between BrAC and TAC so as to better estimate peak BrAC levels.
Methods and materials

Subjects and criteria
A total of 21 healthy men (n=11) and women (n=10) aged 21 to 47 who consume alcohol 1 to 4 days per week were recruited from the community through newspaper, radio, and television advertisements. Exclusion criteria included a body mass index <18 or >30 kg/m 2 , a current or past Axis I psychiatric disorder, pregnancy, a current medical health condition, a history of substance dependence, or a positive urine drug test for the metabolites of drugs of abuse (cocaine, opiates, methamphetamines, barbiturates, benzodiazepines, tetrahydrocannabinol). Participants must also have reported at least one drinking episode during the previous 30 days that would equate to doses of alcohol used in the current study (i.e., five drinks within 2 h). The Institutional Review Board at The University of Texas Health Science Center at San Antonio reviewed and approved the experimental protocol, and written informed consent was obtained prior to study participation. Each participant received $65.00 compensation per day for their participation.
Characteristics of this sample are shown in Table 1 . Compared to women, men were significantly taller, heavier, and had a higher BMI but did not differ on any of the other demographic variables or their alcohol use.
Procedure
Recruitment and study design Those responding to community advertising underwent an initial phone screen to answer a series of questions to determine eligibility. Respondents who met basic criteria were invited to the lab for an in-person interview, at which time they gave written informed consent and completed more detailed study screening. Additional screening included a detailed substance abuse history, a history of alcohol consumed within the last 28 days, a psychiatric screening using the Structured Clinical Interview for DSM-IV-TR Axis I Disorders: Research Version, Non-Patient Edition (First et al. 2001) , urine drug and pregnancy tests, and a medical history and physical examination by a physician's assistant.
Participants were instructed to fast after midnight each day and, upon arrival in the laboratory at 7:30 a.m., provided urine for drug and pregnancy testing and alcohol-free breath samples. On the first day of participation, participants were fitted with a SCRAM-II TM transdermal alcohol monitor and wore the monitor continuously until study completion.
All participants received one, two, three, four, and five beers in ascending order across five study days (usually Monday-Friday consecutively). Participants consumed the alcohol dose designated for each testing day, and TAC and BrAC were monitored throughout the day (described in the following paragraphs). Participants were instructed not to consume alcohol outside of study participation, which was confirmed each morning when TAC readings from the monitor were downloaded. A meal was provided after BrAC levels reached 0.000 (or by 4:00 p.m., whichever came first).
Participants remained in the experimental laboratory environment until their TAC readings were≤0.005 g/dl. This was usually within 3 h after BrAC was 0.000. In the high dose (five beer) condition, this usually occurred by 7 p.m.
Alcohol administration Twelve-ounce Corona beers, 4.6 % alcohol by volume (GrupoModelo S.A.B.. de C.V., Mexico City, Mexico), were administered to the participants by the research staff. The participants consumed one beer on the first study day, increasing their intake by one beer on each subsequent study day, ending with a maximum of five beers on the fifth day. The rate of beer consumption was monitored and standardized. Participants were required to complete each beer within 10 min, and on days when multiple beers were consumed, they were provided at the rate of one every 24 min (i.e., men and women at the same rate).
Breath alcohol monitoring DrägerAlcotest 6810 portable, handheld breathalyzers (Dräger Safety Diagnostics Inc., Irving, TX, USA) were used during the study to measure BrAC. The Dräger breathalyzer uses an electrochemical sensor that reacts specifically to alcohol. The breathalyzer has a 365-day "calibration test lockout" feature that ensures that each breathalyzer is sent to the manufacturer for calibration. A unique breathalyzer was assigned to each participant for the duration of the study. Results were displayed on the device as estimated % blood alcohol concentration (BAC) and recorded by study personnel every 15 min after the first beer was consumed for the first 4 h and then every 30 min until two consecutive readings of 0.000 % BAC were obtained. Breath samples were collected by a standard procedure where participants rinsed their mouths with water twice before each breath sample. Each exhaled air reading was acquired using a new disposable mouthpiece to prevent residual alcohol contamination.
Transdermal alcohol concentration monitoring SCRAM-II TM (Alcohol Monitoring Systems Inc., Highlands Ranch, CO, USA) transdermal alcohol monitors were used to continuously record TAC (e.g., Marques and McKnight 2009; Sakai et al. 2006) . The device also records infrared signals and skin temperature to ensure no tamper or device disruption. TAC monitoring results were downloaded daily using SCRAM Direct Connect TM , a method that allows for the direct connection of the transdermal alcohol monitor to the Web-based application for data download and export. The data are From the time course data, we extracted the "peak BrAC" as the maximum BrAC value observed and "peak TAC" as the maximum TAC value observed and "timeto-peak TAC" as the minutes from the last 0.000 g/dl TAC recording to the peak TAC recording within a drinking episode. Student's t-tests and chi-square analyses were used to identify significant differences between men and women at baseline for continuous and categorical variables, respectively. SAS Proc Mixed (SAS Release 9.2, SAS Institute, Inc., Cary, NC, USA) was used to examine (a) the effect of the numbers of beers consumed on peak BrAC and peak TAC, (b) the effects of sex (male and female) and sex-related variables (weight and BMI) as modulators of peak BrAC and peak TAC, and (c) the relationship between peak BrAC and peak TAC. Post-hoc contrasts examined sex differences at each level of beer consumption. For all analyses using TAC variables to estimate peak BrAC, main effects models, multifactor interactions, linear and quadratic trends, random intercepts for each participant, and random TAC effects (i.e., a random slope) were examined in mixed-effects modeling. Various models were considered to optimize model simplicity and minimize Akaike Information Criterion (AIC; Akaike 1998). A marginal R 2 was used to summarize the amount of variance in actual peak BrAC levels explained by the fixed factors in the final mixed-effects model (Nakagawa and Schielzeth 2013) . These analyses led to the development of a final equation, which was applied to the data collected in a previous study (Dougherty et al. 2012 ) as a cross-validation.
Results
Time course of BrAC and TAC achieved
The actual mean BrAC and TAC levels achieved for men and women after drinking one, two, three, four, and five beers is shown as a function of time in Fig. 1 . For BrAC levels, highly significant (p<0.0001) main effects of beers consumed and time were observed, as Fig. 1 Time course for actual mean BrAC (a and c) and actual mean TAC (b and d) achieved for women and men after drinking one, two, three, four, and five beers was the beer×time interaction (p<0.0023). There was not a main effect of sex (p>0.50), but the sex×beers consumed interaction was highly significant (p<0.0001), indicating that sex differences are an increasing function of beers consumed. For TAC, there also were highly significant effects of beers consumed (p<0.0001) and a beer×time interaction (p<0.0006). There was a marginal main effect tendency of sex (p<0.0751) for TAC but no interactions (p>0.10) with the sex or time factors.
Also seen in Fig. 1 is the fact that the time to peak for both BrAC and TAC varies as a function of the number of beers consumed, which is partly due to the paced drinking procedure. There also was a time lag between the measured TAC and BrAC levels which averaged 128.6 (SEM±5.4) min but actually was an increasing linear function of the number of beers consumed (p<0.001) and showed a non-significant trend for differences (p= 0.06) between men and women. This explains the importance of including "time-to-peak" as a factor in the models estimating peak BrAC from TAC data. Descriptive statistics for the actual peak TAC values observed as well as the actual and estimated peak BrAC are shown in Table 2 as a function of sex and beers consumed. From a total of 104 observations in the experiment, all peak BrAC values were greater than zero, but on the one beer day only, there were eight observations (from three men and five women) out of 21, or 38 %, in which peak TAC=0. There were no observations in which peak TAC=0 for the two through five beer consumption days.
Peak BrAC and peak TAC levels achieved by men and women As shown in Fig. 2a , women had significantly higher peak BrAC levels (F(1, 19)=34.12, p<0.0001) compared to men. Post-hoc contrasts between men and women showed significant differences in peak BrAC levels after two, three, four, and five beers (all p<0.005). Sex-related differences in the slopes of peak BrAC levels were also observed (p<0.001). In contrast to peak BrAC, there were no main sex differences observed in peak TAC levels (Fig. 2b, F(1, 19) =2.88, p=0.11) or in the slopes of peak TAC levels as a function of beers consumed (p=0.34).
Unaccounted sex differences in the relationship between BrAC and TAC Correlations between peak BrAC and peak TAC levels for women and men are shown in Fig. 3 . While women had significantly higher peak BrAC levels than men (p<0.0001), these elevations were not reflected in higher TAC readings. This discrepancy was observed as a significant sex-related Table 2 Means (M), standard deviations (SD), and ranges as a function of the number of beers consumed for peak TAC, peak BrAC, and estimated peak BrAC (Est. BrAC) for men and women Sample size was n=11 men and n=10 women except that n=10 men for the five-beer condition due to device failure difference in slope (p=0.005), such that males had steeper slopes than females. Developing a statistical model incorporating sex in the estimation of peak BrAC from TAC data Data from all beers consumed were used in the model derivation, which included 96 observations with nonzero peak TAC values from the 21 participants. For those with zero peak TAC, the corresponding estimated peak BrAC was set at zero. We systematically considered adding the sex and sex-related variables (weight and BMI) alone and as two-and three-factor interactions to our original model estimating peak BrAC from the peak TAC and time-to-peak TAC variables. Sex, weight, and BMI were each considered separately and were statistically significant contributors in several models. However, these three variables were highly inter-correlated (all p<0.001), and so only one of these at a time was included in any particular model. Inclusion of sex in the model instead of weight or BMI achieved the best AIC values. Neither the addition of weight, BMI, or their substitution for the sex variable was superior to the simpler model including only sex. The optimal model selected for its simplicity and AIC optimization was determined to be the following equation (i.e., the fixed-effect components of the final mixed-effects model): estimated peak BrAC=0.02158±0.3940 * peak TAC ±0.000149 * time-to-peak TAC−0.00366 * sex−0.1887 * peak TAC * sex. Figure 4a shows that this equation resulted in a highly significant correlation between the estimated and the actual peak BrAC levels. This model significantly estimated peak BrAC with a high R 2 of .76 (i.e., 76 % of the variance in the peak BrAC). Post hoc correlations of estimated vs. actual peak BrAC for each level of beer drinking also showed highly significant correlations (all p<0.001) for drinking two to five beers, but not for one beer (p=0.40), and there were no significant differences between the mean estimated and mean actual peak BrACs at any beer level (all p >0.20). Descriptive statistics for estimated peak BrAC are shown in Table 2 . Finally, we further validated the model by showing that the estimated peak BrAC levels using this equation also correlated highly with the observed peak BrAC levels from the previous study (Dougherty et al. 2012 ), Spearman r s =0.86, p<0.0001 (Fig. 4b ).
Discussion
The current study was designed to improve our previously reported (Dougherty et al. 2012 ) ability to use peak TAC readings to estimate peak BrAC levels by accounting for known and possible sex-related differences. This was achieved by having men and women both drink varying numbers of beers at the same rate to properly assess the effects of sex on the peak BrAC and TAC parameter readings. BrAC and TAC were measured concurrently to determine whether Fig. 2 Linear regressions of a peak BrAC levels in % BAC and b peak TAC levels in g/dl shown by number of beers consumed in the five drinking conditions, plotting men (cross, N=54 observations) and women (open circle, N=50 observations) separately Fig. 3 Associations between actual peak BrAC (% BAC) and peak TAC (g/dl) levels from current data, plotting men (cross, N=54 observations) and women (open circle, N=50 observations) separately known sex differences in blood alcohol would similarly affect TAC readings and/or affect peak BrAC predictions by our statistical model. We did observe that the actual peak BrAC levels were significantly higher in women compared to men, confirming previous observations of sex differences in the blood levels of alcohol attributable to differential absorption and distribution of alcohol in women (Baraona et al. 2001; Dettling et al. 2007; Jones and Jones 1976) . Comparable readings in TAC did not show significant sex differences, but we did observe significant sex-dependent differences in the relationship between BrAC and TAC. We concluded that our statistical model to estimate peak BrAC levels from TAC data needed to include sex in the model to properly account for these effects. Using the actual TAC and BrAC data, and accounting for sex, we developed a statistical model that could account for 76 % of the variance (R 2 ) in peak BrAC. The optimal model included three variables: peak TAC, time-topeak TAC, and sex. Lastly, to further validate the model, we applied it to an independent dataset collected in a previous study (Dougherty et al. 2012) and found that it accounted for similar amounts of variance.
It is worth noting that while positive TAC readings were recorded for all participants when two or more beers were consumed, in a substantial percentage of cases (38 %) no positive TAC readings were recorded after drinking only one beer (a higher percentage of women failed to achieve a positive TAC reading than men). This suggests that the transdermal alcohol monitoring may not be adequate in situations where the goal is to confirm abstinence. On the other hand, there is evidence that suggests that lower levels of drinking may be adequately discriminated from higher levels of drinking using transdermal alcohol monitoring. For example, we recently reported that a TAC cutoff of 0.024 g/dl could discriminate between participants who drank one to two drinks from those who consumed a larger number of drinks (Dougherty et al. 2012) . Transdermal alcohol monitoring may be most appropriate in cases where research or clinical interventions focus on achieving moderation (rather than abstinence), which may be more consistent with more recent outcome goals (see Carey et al. 2007) .
We also confirmed previous findings that peak TAC readings show a time lag delay behind peak BrAC readings (Marques and McKnight 2007; Sakai et al 2006; Swift 2003) . Marques and McKnight (2007, 2009) , using a SCRAM monitor, reported an average of 4.5 h time lag between BrAC and TAC readings. They used an older model of the SCRAM device which had problems with water accumulation inside the unit over time which could dilute the alcohol, resulting in a delay in TAC readings. In the current study, the newest generation of the SCRAM device was used (SCRAM-II TM ) in which the company has reportedly fixed the water accumulation problem. Each participant wore a newly calibrated SCRAM-II device for the course of 5 days and the monitors were checked daily, assuring that wearrelated deterioration over time would not occur. Under the conditions of our study, we observed an overall average of 129 min in time lag between peak BrAC and peak TAC, but importantly, we also found that the time lag was an increasing function of the number of beers. This finding may relate to Marques and McKnight's report that the rate elimination slope of TAC is more delayed than that of blood alcohol concentrations.
We also found that the relationship between peak TAC and peak BrAC differs in women compared to men; compared to actual peak BrAC, the peak TAC readings were relatively lower in women than in men. This finding confirms what was reported by Marques and McKnight (2007, 2009) who observed that women's peak TACs were 30.5 % lower than their peak BrACs, whereas men's peak TAC were 14.6 % lower than their peak BrACs. This phenomenon was observed using two different transdermal alcohol monitoring devices, including an older version of the SCRAM ankle monitor and the Wrist Transdermal Alcohol Sensor (WrisTAS™) from Giner Inc. The reason for this lower peak TAC relative to peak BrAC in women is unknown but may be related to sex differences in the skin. The skin of men and women differs Fig. 4 Scatterplot of association between actual peak BrAC (% BAC) and estimated peak BrAC (% BAC) using the model described herein for a the current study's data and b our previous study's data (Dougherty et al. 2012) . Data are all values collected from all participants across all drinking conditions broken down as two regression slopes separately for men and women anatomically, physiologically, and biochemically (reviewed in Giacomoni et al. (2009) and Tur (1997) ). Though differences in skin thickness run counter to our findings, the skin of men is thicker than that of women in many areas of the body, including calf sites and forearms (Hattori and Okamoto 1993; Sandby-Møller et al. 2003; Tur 1997) . Women also are known to have a significantly higher pH on their outermost layer of skin, stratum corneum, than men (Jacobi et al. 2005) . Finally, women have a larger volume of subcutaneous fat compared to men in many areas of the body, including abdomen, calf, and forearm (Cartier et al. 2009; Hattori et al. 1991; Liu et al. 2010; Westerbacka et al. 2004) . As Marques and McKnight (2007) indicate: "…it would be interesting to know whether skin pH or the higher subcutaneous adiposity of females accounts for flattening of the TAC peaks". Taken together, the sex-related differences in peak BrAC to peak TAC ratios underscore the importance of accounting for sex in any model using TAC data to estimate peak BrAC levels.
The study has some limitations due to the controlled laboratory conditions under which participants were required to drink alcohol. More specifically, the specific amounts and rates of alcohol drinking may differ from real-world drinking behaviors. Clearly, variations in the rate of alcohol consumption may affect the TAC data variables used in the model for BrAC prediction (e.g., time-to-peak TAC and peak TAC). However, our findings of a high correlation between the actual BrAC and the model-corrected estimate of peak BrAC over a range of alcohol amounts (one to five beers) suggest that these relationships are maintained during the course of a typical binge episode. Future studies should determine how alcohol drinking rate may affect these parameters in the prediction of BrAC levels and to extend these estimates and predictions to the outpatient environment where naturalistic drinking occurs. Preliminary data from our laboratory suggests that variations in rates of consumption do not affect the ability of our models to estimate peak BrAC.
In summary, the present findings indicate that it is important to account for sex in the model using TAC data to accurately estimate peak BrAC in both men and women. Peak breath alcohol or peak blood concentrations are used to describe maximum levels of intoxication, which indeed are the most clinically relevant outcome relating to both health and safety guidelines. Clinical researchers, and perhaps practitioners, could benefit by using transdermal alcohol monitoring, which is a convenient, less burdensome, and continuous surrogate for more intrusive and less accurate measures (e.g., self-report and biological monitoring) of intoxication levels obtained only from peak BrAC readings. Our future work is focusing on developing methods to use these TAC data to estimate standardized units of alcohol consumed. The ability to better estimate both peak intoxication and number of drinks consumed will be important advancements in the field, which could have a significant impact on both research and clinical interventions for alcohol abuse and dependence.
